Cresco Labs CRLBF
OTC CRLBF
$0.82 +0.04 (+4.94%)
At close: Aug 19, 2026 · 3:30 PM UTC

Cresco Labs (CRLBF) Shares Outstanding (2019 - 2026)

Cresco Labs' (CRLBF) quarterly Shares Outstanding (Entity) came in at $364.2 million in Q1 2026, up 3.99% YoY from $350.2 million in Q1 2025, and up 6.12% on a QoQ basis from $343.2 million in Q4 2025.

Cresco Labs (CRLBF) Shares Outstanding (2019 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 8 years of Shares Outstanding (Entity) data on file, last reported at $364.2 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 3.99% year-over-year to $364.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $364.2 million (up 3.99% YoY) and the FY2025 annual result came in at $343.2 million, up 3.54% from the prior year.
  • Shares Outstanding (Entity) rose to $364.2 million in Q1 2026, from $343.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $364.2 million in Q1 2026 to a low of $281.0 million in Q4 2022.
  • A 5-year average of $328.3 million and a median of $337.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) rose 23.15% — and 2025, when it grew 2.35%.
  • Tracing CRLBF's Shares Outstanding (Entity) over 5 years: stood at $281.0 million in 2022, then advanced by 14.15% to $320.8 million in 2023, then increased by 3.35% to $331.5 million in 2024, then gained by 3.54% to $343.2 million in 2025, then increased by 6.12% to $364.2 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $364.2 million (Q1 2026), $343.2 million (Q4 2025), and $355.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 43.76 Bn 42.79 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 43.38 Bn 39.73 Bn 2.15 Bn 1.17 Bn
3 Zoetis 31.61 Bn 29.93 Bn 1.05 Bn 417.60 Mn
4 Takeda Pharmaceutical 28.64 Bn 22.84 Bn 5.10 Bn 1.58 Bn
5 United Therapeutics 22.20 Bn 19.54 Bn 683.80 Mn 42.60 Mn
6 Viatris 18.82 Bn 17.93 Bn 1.46 Bn 1.16 Bn
7 Neurocrine Biosciences 15.67 Bn 15.28 Bn 935.80 Mn 101.00 Mn
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn 499.50 Mn
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - 832.44 Mn
10 Cresco Labs 291.27 Mn 227.16 Mn 86.95 Mn 370.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 364.23 Mn
Dec 31, 2025 355.01 Mn
Sep 30, 2025 355.54 Mn
Jun 30, 2025 354.29 Mn
Mar 31, 2025 350.24 Mn
Dec 31, 2024 345.47 Mn
Sep 30, 2024 347.36 Mn
Jun 30, 2024 344.93 Mn
Mar 31, 2024 341.63 Mn
Dec 31, 2023 323.82 Mn
Sep 30, 2023 337.47 Mn
Jun 30, 2023 313.62 Mn
Mar 31, 2023 304.71 Mn
Dec 31, 2022 298.16 Mn
Sep 30, 2022 301.12 Mn
Jun 30, 2022 296.32 Mn
Mar 31, 2022 292.72 Mn
Dec 31, 2021 262.33 Mn
Sep 30, 2021 271.18 Mn
Jun 30, 2021 260.04 Mn